| Ms Peggy Jo Schuelke, RN, MS, CNP | |
|
103 E. Third Street, Revillo, SD 57259 | |
| (605) 623-4695 | |
| (605) 623-4318 |
| Full Name | Ms Peggy Jo Schuelke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 32 Years |
| Location | 103 E. Third Street, Revillo, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134299100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP000126 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milbank Area Hospital/avera Health | Milbank, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
News Archive
The University of Texas at San Antonio (UTSA) announced today that it received $9.2 million in stimulus funding for scientific research and university recruitment during 2009. The majority of that funding, from the National Institutes of Health and the National Science Foundation, will support researchers in UTSA's College of Sciences and College of Engineering.
Findings published in the Journal of Pediatrics describe growth factors in cord blood that may identify premature infants at risk for bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) – an often fatal lung disease in which the vessels carrying blood from the heart to the lungs become narrowed and dysfunctional.
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
A pivotal registration trial to evaluate in-home use of the Medtronic MiniMed(r) 670G hybrid closed-loop insulin delivery system over 3 months showed a significant reduction in HbA1c levels for both adolescents and adults with type 1 diabetes.
OncoEthix, the Swiss-based specialist in oncology drug development, announces progress in its Phase I study of OTX015, a novel BET bromodomain inhibitor, with the first dosing of a patient.
› Verified 8 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
The University of Texas at San Antonio (UTSA) announced today that it received $9.2 million in stimulus funding for scientific research and university recruitment during 2009. The majority of that funding, from the National Institutes of Health and the National Science Foundation, will support researchers in UTSA's College of Sciences and College of Engineering.
Findings published in the Journal of Pediatrics describe growth factors in cord blood that may identify premature infants at risk for bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) – an often fatal lung disease in which the vessels carrying blood from the heart to the lungs become narrowed and dysfunctional.
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
A pivotal registration trial to evaluate in-home use of the Medtronic MiniMed(r) 670G hybrid closed-loop insulin delivery system over 3 months showed a significant reduction in HbA1c levels for both adolescents and adults with type 1 diabetes.
OncoEthix, the Swiss-based specialist in oncology drug development, announces progress in its Phase I study of OTX015, a novel BET bromodomain inhibitor, with the first dosing of a patient.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Peggy Jo Schuelke, RN, MS, CNP 15754 483rd Ave, Revillo, SD 57259-6311 Ph: (605) 623-4228 | Ms Peggy Jo Schuelke, RN, MS, CNP 103 E. Third Street, Revillo, SD 57259 Ph: (605) 623-4695 |
News Archive
The University of Texas at San Antonio (UTSA) announced today that it received $9.2 million in stimulus funding for scientific research and university recruitment during 2009. The majority of that funding, from the National Institutes of Health and the National Science Foundation, will support researchers in UTSA's College of Sciences and College of Engineering.
Findings published in the Journal of Pediatrics describe growth factors in cord blood that may identify premature infants at risk for bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) – an often fatal lung disease in which the vessels carrying blood from the heart to the lungs become narrowed and dysfunctional.
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
A pivotal registration trial to evaluate in-home use of the Medtronic MiniMed(r) 670G hybrid closed-loop insulin delivery system over 3 months showed a significant reduction in HbA1c levels for both adolescents and adults with type 1 diabetes.
OncoEthix, the Swiss-based specialist in oncology drug development, announces progress in its Phase I study of OTX015, a novel BET bromodomain inhibitor, with the first dosing of a patient.
› Verified 8 days ago